Nanoparticles + light = dead tumor cells

Medical physicists at the University of Virginia have created a novel way to kill tumor cells using nanoparticles and light. The technique, devised by Wensha Yang, an instructor in radiation oncology at the University of Virginia, and colleagues Ke Sheng, Paul W. Read, James M. Larner, and Brian P. Helmke, employs quantum dots. Quantum dots are semiconductor nanostructures, 25 billionths of a meter in diameter, which can confine electrons in three dimensions and emit light when exposed to ultraviolet radiation.

Yang and his colleagues realized that quantum dots also give off light when exposed to megavoltage x-rays, such as those used in cancer radiotherapy. That property, the scientists realized, makes quantum dots an ideal mediator in therapies employing light-activated compounds to treat cancer.

A compound called Photofrin is the only photosensitizer currently approved by the FDA. Photofrin is absorbed by cancer cells and, upon exposure to light, becomes active and kills cells. It is currently used to treat certain kinds of shallowly located tumors, but Yang and his colleagues realized that combing Photofrin with quantum dots could create an efficient method to kill even deeply seated cancer cells. Upon exposure to high doses of radiation, the dots become luminescent and emit light; that light triggers the cancer-killing activity of the Photofrin. In theory, the process, which so far has been studied only in cancer cells grown in culture, could work on tumors located too deep within the body to be reached by an external light source.

To prevent normal tissues from being affected by the treatment, the toxicity of the quantum dot-Photofrin conjugate is only activated when radiation is applied. Also, the area to be treated is targeted with conformal radiation, which is delivered with high precision within the three-dimensional contours of the tumor, with minimal spillover to surrounding healthy tissues. As a result, Yang says, "the toxicity of the drug is substantially lower in the lower radiation dose area" outside the boundaries of the tumor. In tests on human lung carcinoma cells, the process resulted in a 2-6 times lower tumor cell survival compared to radiation alone, but with minimal toxicity to nearby cells.

Original here